Jung, S., Kim, D. H., Choi, Y. J., Kim, S. Y., Park, H., Lee, H., . . . Rho, J. K. (2021). Contribution of p53 in sensitivity to EGFR tyrosine kinase inhibitors in non-small cell lung cancer. Nature Portfolio.
Style de citation Chicago (17e éd.)Jung, Sangyong, et al. Contribution of P53 in Sensitivity to EGFR Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer. Nature Portfolio, 2021.
Style de citation MLA (8e éd.)Jung, Sangyong, et al. Contribution of P53 in Sensitivity to EGFR Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer. Nature Portfolio, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.